Back
Vir Biotechnology 10K Form
Sell
27
VIR
Vir Biotechnology
Last Price:
$4.52
Seasonality Move:
7.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VIR News And Ratings
See the #1 stock for the next 7 days that we like better than VIR
VIR Financial Statistics
Sales & Book Value
| Annual Sales: | $63.7M |
|---|---|
| Cash Flow: | $-79.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.56 |
| Price / Book: | 0.63 |
Profitability
| EPS (TTM): | -4.22000 |
|---|---|
| Net Income (TTM): | $-577.6M |
| Gross Margin: | $62.9M |
| Return on Equity: | -45.02% |
| Return on Assets: | -37.66% |
Vir Biotechnology Earnings Forecast
Key Vir Biotechnology Financial Ratios
-
The Gross Profit Margin over the past 6 years for VIR is 98.67%.
-
The Selling, General & Administrative Expenses for VIR have been equal to 186.83% of Gross Profit Margin.
-
The Research & Development expenses have been 794.98% of Revenue.
-
The Net Earning history of VIR is -819.25% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Vir Biotechnology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VIR |
| CUSIP: | 92764N |
| Website: | vir.bio |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.79 |
| Quick Ratio: | 5.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VIR Technical Analysis vs Fundamental Analysis
Sell
27
Vir Biotechnology (VIR)
is a Sell
Is Vir Biotechnology a Buy or a Sell?
-
Vir Biotechnology stock is rated a SellThe current Vir Biotechnology [VIR] share price is $4.73. The Score for VIR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.